Skip to main content
IBRX
NASDAQ Life Sciences

ImmunityBio Secures Five US Patents for Anktiva, Extending Protection to 2035

Tom Rudovsky · Reported by Wiseek News
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$8.029
Mkt Cap
$8.379B
52W Low
$1.95
52W High
$12.43
52W Position info
312% above low
Off High info
35% below high
Rel. Volume info
0.5× avg
Market data snapshot near publication time

IBRX has more than doubled off its 52-week low of $1.95.

Summary

ImmunityBio has announced the grant of five new U.S. patents for its key drug Anktiva (N-803) plus BCG in NMIBC. These patents provide intellectual property protection for treatment methods, dosing, formulations, and kits, extending through at least 2035. This is a significant positive development for the company, as it substantially strengthens the long-term competitive position and revenue potential of a critical product. The headline also references a "US Supply Deal," which appears to be a reiteration of the exclusive development and supply agreement with Japan BCG Laboratory that was previously announced via an 8-K and news on May 18th. While the supply deal is not new information, the patent wins are material and de-risk Anktiva's future, providing a strong catalyst for the stock.

At the time of this announcement, IBRX was trading at $8.03 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $8.4B. The 52-week trading range was $1.95 to $12.43. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

IBRX - Latest Insights

IBRX
Oct 16, 2026, 11:49 AM EDT
Source: BusinessWire
Importance Score:
7
Price at Filing: $9.42
Real-time Price: $8.06 info
Change: -$1.36 (-14%) info
Market Cap: $8.489B info
IBRX
Oct 14, 2026, 11:31 AM EDT
Source: Reuters
Importance Score:
9
Price at Filing: $9.74
Real-time Price: $8.06 info
Change: -$1.68 (-17%) info
Market Cap: $8.489B info
IBRX
Oct 05, 2026, 7:00 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $10.63
Real-time Price: $8.06 info
Change: -$2.57 (-24%) info
Market Cap: $8.489B info
IBRX
Aug 10, 2026, 7:37 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $7.62
Real-time Price: $8.06 info
Change: +$0.440 (+6%) info
Market Cap: $8.489B info
IBRX
Aug 06, 2026, 6:50 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $7.29
Real-time Price: $8.06 info
Change: +$0.770 (+11%) info
Market Cap: $8.489B info